LVAD Hemolysis Outcomes Better With Early Surgery? Fewer events, deaths than when waiting for meds to fail, study suggests
Left ventricular assist device (LVAD) recipients with hemolysis who are at risk of device thrombosis might do better with early replacement than waiting for response to more antithrombotic medication, a retrospective study found.